It seems that patients with lung or colorectal cancer have poor enrollment in clinical trials, according to the recent multiregional survey carried out by the authors in a cohort of 8778 patients three to six months after diagnosis. Only 14% of patients have discussed their participation in clinical trials.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Thoracic
October 15, 2014
October 15, 2014
Using a data set of over 76,000 women from the Women's Health Initiative Observational Study, the effects of active and passive smoking on cancer were evaluated. Lung cancer incidence was highest among active smokers (HR 13.44) and was also high among prior smokers (HR 4.20). A prolonged exposure (>30 yr) to passive smoking in the household also
October 14, 2014
This multicenter observational study evaluated midterm outcomes after use of the lung volume reduction endobronchial coil for severe emphysema in 60 pts. The 30-day complication rate was moderate. At 12 mos, the St.
October 14, 2014
Lung cancer cases 2000-2013 in the UK Health Improvement Network were evaluated for factors associated with early death (within 90 days of diagnosis) vs later death. Risk factors for early death included male sex, older age, current smoking, social deprivation, and rural location. Those experiencing early death saw their primary care physicians mor
October 14, 2014
This video demonstrates how to use a curved stapler for superficial and deep lung resections.
October 13, 2014
Recorded during the the 2014 EACTS Annual Meeting in Milan, Italy, this roundtable discussion addresses the duty of candor in medical practice.
October 12, 2014
This is a fabulous paper comparing VATS versus open lobectomy. The 5 year survival is the same, the hospital stay is 2 days less and the in hospital mortality is slightly lower
October 12, 2014
EACTS Secretary General A. Pieter Kappetein discusses highlights of the 2014 EACTS Annual Meeting taking place in Milan, Italy.
October 11, 2014
EACTS President Paul Van Schil and Past President Jose Pomar discuss exciting aspects and special features of the 2014 EACTS Annual Meeting taking place in Milan, Italy.
October 9, 2014
This paper presents an update on diagnostic and prognostic biomarkers in malignant pleural mesothelioma considering also recent molecular biologic achievements as microRNA and genomic sequencing.